News | October 19, 2011

Enrollment Competed in Benign Stricture Study of WallFlex Biliary RX Stent

 

October 19, 2011 – Boston Scientific has completed enrollment in a clinical trial to evaluate its WallFlex Biliary RX fully covered stent for the treatment of benign bile duct strictures (narrowing or blockages).  This multi-center, prospective study enrolled 187 patients at 13 centers in 11 countries worldwide.  Lead investigators in the study are Professor Jacques Deviere, M.D., Ph.D., of Hospital Erasme in Brussels, and Professor Guido Costamagna, M.D., of Policlinico A. Gemelli in Rome.

The study includes patients with bile duct strictures associated with post liver transplant anastomosis (connection of two structures), prior abdominal surgery such as cholecystectomy (gall bladder removal) and chronic pancreatitis (inflammation of the pancreas).  The WallFlex Biliary RX Fully Covered Stent will remain in patients five to 11 months depending on the nature of the stricture.  The trial will evaluate the removal of the stents from patients as well as the effectiveness of temporary stenting for long-term benign biliary stricture resolution.  Patients will be followed for five years after stent removal.  

"This is a key milestone for this important trial," said Deviere.  "We look forward to the findings, which will determine the potential benefits of this stent as a less-invasive alternative to surgery in these types of patients and as an endoscopic treatment option that may require fewer ERCP(1) procedures than plastic stenting."

The WallFlex Biliary RX Stent is constructed of braided Platinol (platinum-cored Nitinol) wire and features three key attributes: radial force to help maintain duct patency and resist migration; flexibility to aid in conforming to tortuous anatomies; and full-length radiopacity to enhance stent visibility under fluoroscopy.  The WallFlex Biliary RX family of stents is available in fully covered, partially covered and uncovered versions.  Covered stents have a silicone polymer Permalume Coating designed to reduce the potential for tumor ingrowth, and an integrated retrieval loop for removing or repositioning the stent during the initial procedure in the event of incorrect placement.

The WallFlex Biliary RX fully covered, partially covered and uncovered stents are currently cleared in the United States and CE Mark countries for the palliative treatment of malignant bile duct strictures.  The WallFlex Biliary RX fully covered stent was CE Marked in 2010 for an expanded indication to treat benign biliary strictures.  The safety and effectiveness of the WallFlex Biliary RX Stenting System for use in the vascular system have not been established.  

For more information: www.bostonscientific.com

 

Related Content

The OEC One mobile C-arm from GE Healthcare

The OEC One mobile C-arm from GE Healthcare. Image courtesy of GE Healthcare

Feature | Mobile C-Arms | April 18, 2018 | Jeff Zagoudis
The market for mobile C-arm technology has been steady for the last several years, according to Jamie Dildy, BS, R.T.
Chest X-ray AI Algorithm Correctly Identifies Lung Disease for Dubai Health Authority
Feature | Artificial Intelligence | April 17, 2018
The Dubai Health Authority (DHA) announced the preliminary results of a chest X-ray artificial intelligence (AI)...
First Patient Treated in Online Adaptive Radiotherapy Trial With CyberKnife System
News | Stereotactic Body Radiation Therapy (SBRT) | April 06, 2018
Accuray Inc. and Erasmus MC announced the first patient has been successfully treated using an online-adaptive (OA)...
News | Endoscopes | April 02, 2018
Results from a recent prospective trial found the Wide Area Transepithelial Sampling with 3D Tissue Analysis (WATS3D)...
Medical Societies Issue Revised, Patient-Centered Measures for Stroke Interventions
News | Stroke | April 02, 2018
Revised guidelines for the nonsurgical, image-guided interventional treatment of acute ischemic stroke will ensure...
Radiologist Uses Virtual Reality as Interventional Radiology Teaching Tool

Ziv Haskal, M.D., of the University of Virginia Health System, steps into virtual reality. Image courtesy of Josh Barney, UVA Health System

News | Interventional Radiology | March 27, 2018
Physicians, trainees and even laypeople can now stand right beside an expert radiologist as he performs one of the most...
Edwards Completes Enrollment in PARTNER 3 Low-Risk CT Sub-Study
News | Computed Tomography (CT) | March 27, 2018
March 27, 2018 — Edwards Lifesciences Corp.
Combination Radiotherapy Beneficial in Treating Prostate Cancer
News | Prostate Cancer | March 27, 2018
March 27, 2018 — While there are many treatment options for men with...
3-D Printed Models Improve Medical Student Training
News | Medical 3-D Printing | March 23, 2018
March 23, 2018 — A relatively inexpensive...
Overlay Init